Octave Bioscience, Inc., a commercial stage precision medicine company pioneering biomarker driven solutions for multiple ...

Skye Bioscience Inc. (NASDAQ:SKYE) shares gained 5.3% in premarket trading on Monday after the company revealed a ...

Harvard Bioscience Inc (NASDAQ:HBIO) is set to release its Q2 2025 earnings on Aug 11, 2025. The consensus estimate for Q2 2025 revenue is $20.40 million, and the earnings are expected to come in at ...

Harvard Bioscience, Inc. will release its financial results for the fourth quarter of 2024 on March 12, 2025, before the market opens, and will host a conference call at 8:00 a.m. Eastern Time to ...

Good day, and welcome to the Third Quarter 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

We recently compiled a list of 7 Best Russell 2000 Stocks to Buy According to Analysts. In this article, we will look at where Skye Bioscience, Inc. (NASDAQ:SKYE) ranks among the best Russell 2000 ...

Daré Bioscience, Inc. beats earnings expectations. Reported EPS is $-0.45, expectations were $-0.55. Operator: Welcome to the conference call hosted by Daré Bioscience Therapeutics Company’s Second ...

PURE Bioscience, Inc. (OTCQB: PURE) (“PURE” or the “Company”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced that the Company has appointed Jeff ...

Good day, and welcome to the Second Quarter 2025 Harvard Bioscience Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference ...